Diagnosis of liver diseases using machine learning

Author(s):  
Sumedh Sontakke ◽  
Jay Lohokare ◽  
Reshul Dani

Advancement in medical science has always been one of the most vital aspects of the human race. With the progress in technology, the use of modern techniques and equipment is always imposed on treatment purposes. Nowadays, machine learning techniques have widely been used in medical science for assuring accuracy. In this work, we have constructed computational model building techniques for liver disease prediction accurately. We used some efficient classification algorithms: Random Forest, Perceptron, Decision Tree, K-Nearest Neighbors (KNN), and Support Vector Machine (SVM) for predicting liver diseases. Our works provide the implementation of hybrid model construction and comparative analysis for improving prediction performance. At first, classification algorithms are applied to the original liver patient datasets collected from the UCI repository. Then we analyzed features and tweaked to improve the performance of our predictor and made a comparative analysis among the classifiers. We examined that, KNN algorithm outperformed all other techniques with feature selection.


2020 ◽  
Author(s):  
PSM Keerthana ◽  
Nimish Phalinkar ◽  
Riya Mehere ◽  
Koppula Bhanu Prakash Reddy ◽  
Nidhi Lal

2020 ◽  
Vol 43 ◽  
Author(s):  
Myrthe Faber

Abstract Gilead et al. state that abstraction supports mental travel, and that mental travel critically relies on abstraction. I propose an important addition to this theoretical framework, namely that mental travel might also support abstraction. Specifically, I argue that spontaneous mental travel (mind wandering), much like data augmentation in machine learning, provides variability in mental content and context necessary for abstraction.


2020 ◽  
Vol 48 (5) ◽  
pp. 2295-2305
Author(s):  
Jiawei Zhang ◽  
Dandan Li ◽  
Rui Zhang ◽  
Peng Gao ◽  
Rongxue Peng ◽  
...  

The role of miR-21 in the pathogenesis of various liver diseases, together with the possibility of detecting microRNA in the circulation, makes miR-21 a potential biomarker for noninvasive detection. In this review, we summarize the potential utility of extracellular miR-21 in the clinical management of hepatic disease patients and compared it with the current clinical practice. MiR-21 shows screening and prognostic value for liver cancer. In liver cirrhosis, miR-21 may serve as a biomarker for the differentiating diagnosis and prognosis. MiR-21 is also a potential biomarker for the severity of hepatitis. We elucidate the disease condition under which miR-21 testing can reach the expected performance. Though miR-21 is a key regulator of liver diseases, microRNAs coordinate with each other in the complex regulatory network. As a result, the performance of miR-21 is better when combined with other microRNAs or classical biomarkers under certain clinical circumstances.


2001 ◽  
Vol 120 (5) ◽  
pp. A725-A725
Author(s):  
M DORE ◽  
G REALDI ◽  
D MURA ◽  
D GRAHAM ◽  
A SEPULVEDA

Sign in / Sign up

Export Citation Format

Share Document